Dermatol. praxi. 2012;6(3):138-140

Brunsting-Perry pemphigoid - clinical case

MUDr.Lubomír Drlík1, MUDr.Lenka Slezáková1, doc.MUDr.Lumír Pock, CSc.2
1 Dermatovenerologické oddělení, Šumperská nemocnice a. s.

Brunsting-Perry pemphigoid is a rare bullous dermatosis with not entirely clear etiopathogenesis. The disease is considered to be a localized form of cicatricial pemphigoid or one of the forms of epidermolysis bullosa acquisita. The authors present a case of 52-year-old man with recidiving manifestations in the oral mucosa and skin manifestations on the crown. The pacient was treated with combined prednison and azathioprin therapy.

Keywords: cicatricial pemphigoid, autoimmune disease, direct immunofluorescence microscopy

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drlík L, Slezáková L, Pock L. Brunsting-Perry pemphigoid - clinical case. Dermatol. praxi. 2012;6(3):138-140.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baldwin H, Lynfield Y. Brunsting-Perry cicatricial pemphigoid praecipitated by trauma, Arch Dermatol, 1991; 127(6): 911-912. Go to original source... Go to PubMed...
    2. Brunsting LA, Perry HO. Benign pemphigoid: a report of seven cases with chronic, scarring, herpetiform plaques about the head and nack, Arch Dermatol, 1957; 75(4): 489-501. Go to original source... Go to PubMed...
    3. Daito J, Katoh N, Asai J, et al. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180, Br J Dermatol, 2008; 159(4): 984-986. Go to original source... Go to PubMed...
    4. Demitsu T, Kakurai M, Yoneda K, et al. Localized pemphigoid (Brunsting-Perry type) with IgG antibody to BP180 NC16a domain resembling lupus erythematosus succesfully treated with topical tacrolimus therapy, JEADV, 2009; 23(1): 79-80. Go to original source... Go to PubMed...
    5. Chen M, Kim GH, Prakash L, et al. Epidermolysis bullosa acquisita: autoimunity to anchoring fibril collagen, Autoimunity, 2012; 45(1): 91-101. Go to original source... Go to PubMed...
    6. Jedličková H. Imunofluorescenční vyšetření v dermatologii, Čes.-slov. Derm 2011; 86(4): 175-184.
    7. Jedlickova H, Niedermeier A, Zgažarová S, Hertl M. Brunsting-Perry pemphigoid of the Scalp with Antibodies against Laminin 332, Dermatology 2011; 222: 193-195. Go to original source... Go to PubMed...
    8. Kim JH, Kim YH, Kim SC. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases, Acta Derm Venereol, 2011; 91(3): 307-312. Go to original source... Go to PubMed...
    9. Kneisel A, Hertl M. Blasenbildende Autoimmundermatosen. Teil 1. Klinik, JDDG, 2011; 9: 844-856. Go to original source...
    10. Kodet O, Dundr P, Lacina L, Bělohradská H, Štork J. Klinický případ: Bizarní chronické eroze na obličeji. Čes.-slov. Derm 2011; 86(4): 153-155.
    11. Kurzhais G, Stolz W, Maciejewski W, et al. Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid. Report of a case proved by preembedding immunogold electron microscopy, Arch Dermatol, 1995; 131(5): 580-585. Go to original source... Go to PubMed...
    12. Kurzhais G, Stolz W, Meurer M, et al. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid, Arch Dermatol, 1991; 127(3): 391-395. Go to original source... Go to PubMed...
    13. Leenutaphong V, von Kries R, Plewig G. Localized cicatricial pemphigoid (Brunsting-Perry): electron microscopic study, J Am Acad Dermatol, 1989; 21(5): 1089-1093. Go to original source... Go to PubMed...
    14. Minato H, Ishii N, Fukuda S,  et al. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa, J Dermatol, 2011; 38(9): 887-892. Go to original source... Go to PubMed...
    15. Mittal RR, Kullar J, Sethi PS. Brunsting Perry Cicatricial Pemphigoid, Indian J Dermatol Venereol Leprol, 2000; 66: 304-305.
    16. Monihan JM, Nguen, TH, Guill MA. Brunsting-Perry pemphigoid simulating basal cell carcinoma, J Am Acad Dermatol. 1989; 21(2): 331-334. Go to original source... Go to PubMed...
    17. Poon E, McGrath, JA. Non-specific scalp crusting as a presenting feature of Brunsting-Perry cicatricial pemphigoid, JEADV, 1999; 12(2): 177-178. Go to original source... Go to PubMed...
    18. Sugita Y, Inomata Y, Takahashi M, et al. Autoimmune vesicles on the face and neck. A variant of Brunsting-Perry type localized bullous pemphigoid?, Eur J Derm, 2001; 11(6): 557-559.
    19. Takeichi S, Kubo Y, Arase S, et al. Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure, Eur J Derm, 2009; 19(5): 500-503. Go to original source... Go to PubMed...
    20. Tanaka N, Dainichi T, Ohyama B, et al. A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excelent response to colchicine, J Am Acad Dermatol, 2009; 61(4): 715-719. Go to original source... Go to PubMed...
    21. Wolff K, Goldsmith LA, Katz SI, et al. Fitzpatrik´s dermatology in general medicine, 7th ed., The McGraw-Hill Companies, 2008: 483, ISBN 978-0-07-1466 90-5.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.